BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, November 16, 2025
Breaking News: Trump administration impacts continue to roil the life sciences sector
See today's BioWorld Science
Home
» RET antagonist implicated in Ewing sarcoma and delayed puberty
To read the full story,
subscribe
or
sign in
.
Cancer
RET antagonist implicated in Ewing sarcoma and delayed puberty
Sep. 10, 2025
No Comments
Secreted gonadotropin-releasing hormone (GnRH) acts on the anterior pituitary gland to initiate puberty. Mutations in the protein immunoglobulin superfamily member 10 (IGSF10) have been linked to puberty delay, but the reason has been unclear.
BioWorld Science
Cancer